Morule-like features in pulmonary adenocarcinoma associated with epidermal growth factor receptor mutations: two case reports with targeted next-generation sequencing analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Yoo Jin | - |
dc.contributor.author | Oh, Harim | - |
dc.contributor.author | Kim, Eojin | - |
dc.contributor.author | Ahn, Bokyung | - |
dc.contributor.author | Lee, Jeong Hyeon | - |
dc.contributor.author | Lee, Youngseok | - |
dc.contributor.author | Chae, Yang Seok | - |
dc.contributor.author | Kim, Chul Hwan | - |
dc.date.accessioned | 2021-08-31T15:00:52Z | - |
dc.date.available | 2021-08-31T15:00:52Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 2383-7837 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/58474 | - |
dc.description.abstract | Morules, or morule-like features, can be identified in benign and malignant lesions in various organs. Morular features are unusual in pulmonary adenocarcinoma cases with only 26 cases reported to date. Here, we describe two cases of pulmonary adenocarcinoma with morule-like features in Korean women. One patient had a non-mucinous-type adenocarcinoma in situ and the other had an acinarpredominant adenocarcinoma with a micropapillary component. Both patients showed multiple intra-alveolar, nodular, whorled proliferative foci composed of atypical spindle cells with eosinophilic cytoplasm. Targeted next-generation sequencing was performed on DNA extracted from formalin-fixed paraffin-embedded samples of the tumors. Results showed unusual epidermal growth factor receptor (EGFR) mutations, which are associated with drug resistance to EGFR tyrosine kinase inhibitors, revealing the importance of identifying morule-like features in pulmonary adenocarcinoma and the need for additional study, since there are few reported cases. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC PATHOLOGISTS | - |
dc.subject | LUNG ADENOCARCINOMA | - |
dc.subject | COMPONENTS | - |
dc.subject | CARCINOMA | - |
dc.subject | EGFR | - |
dc.title | Morule-like features in pulmonary adenocarcinoma associated with epidermal growth factor receptor mutations: two case reports with targeted next-generation sequencing analysis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Yoo Jin | - |
dc.contributor.affiliatedAuthor | Kim, Chul Hwan | - |
dc.identifier.doi | 10.4132/jptm.2019.09.30 | - |
dc.identifier.scopusid | 2-s2.0-85078983554 | - |
dc.identifier.wosid | 000507966800010 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, v.54, no.1, pp.119 - 122 | - |
dc.relation.isPartOf | JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE | - |
dc.citation.title | JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE | - |
dc.citation.volume | 54 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 119 | - |
dc.citation.endPage | 122 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002552161 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.subject.keywordPlus | LUNG ADENOCARCINOMA | - |
dc.subject.keywordPlus | COMPONENTS | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | EGFR | - |
dc.subject.keywordAuthor | Morule-like features | - |
dc.subject.keywordAuthor | Pulmonary adenocarcinoma | - |
dc.subject.keywordAuthor | Next-generation sequencing | - |
dc.subject.keywordAuthor | Epidermal growth factor receptor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.